Abstract:Background Digital whole-slide images are a unique way to assess the spatial context of the career microenvironment. Exploring these spatial characteristics will enable us to better identify cross-level molecular markers that could deepen our understanding of cancer biology and related patient outcomes. Methods We proposed a graph neural network approach that emphasises spatialisation of tumour tiles towards a comprehensive evaluation of predicting cross-level molecular profiles of genetic mutations, copy number alterations, and functional protein expressions from whole-slide images. We introduced a transformation strategy that converts whole-slide image scans into graph-structured data to address the spatial heterogeneity of colon cancer. We developed and assessed the performance of the model on The Cancer Genome Atlas colon adenocarcinoma (TCGA-COAD) and validated it on two external datasets (ie, The Cancer Genome Atlas rectum adenocarcinoma [TCGA-READ] and Clinical Proteomic Tumor Analysis Consortium colon adenocarcinoma [CPTAC-COAD]). We also predicted microsatellite instability and result interpretability. Findings The model was developed on 459 colon tumour whole-slide images from TCGA-COAD, and externally validated on 165 rectum tumour whole-slide images from TCGA-READ and 161 colon tumour whole-slide images from CPTAC-COAD. For TCGA cohorts, our method accurately predicted the molecular classes of the gene mutations (area under the curve [AUCs] from 82.54 [95% CI 77.41-87.14] to 87.08 [83-28-90.82] on TCGA-COAD, and AUCs from 70.46 [61.37-79.61] to 81.80 [72.20-89.70] on TCGA-READ), along with genes with copy number alterations (AUCs from 81.98 [73.3449-68] to 90.55 [86.02-94.89] on TCGA-COAD, and AUCs from 62.05 [48.94-73-46] to 76.48 [64.78-86.71] on TCGA-READ), microsatellite instability (MSI) status classification (AUC 83.92 [77.41-87.59] on TCGA-COAD, and AUC 61.28 [53.28-67.93] on TCGA-READ), and protein expressions (AUCs from 85.57 [81.16-89.44] to 89.64 [86.29-93.19] on TCGA-COAD, and AUCs from 51.77 [42.53-61.83] to 59.79 [50.79-68.57] on TCGA-READ). For the CPTAC-COAD cohort, our model predicted a panel of gene mutations with AUC values from 63.74 (95% CI 52.92-75.37) to 82.90 (73.69-90.71), genes with copy number alterations with AUC values from 62.39 (51.37-73.76) to 86.08 (79.67-91.74), and MSI status prediction with AUC value of 73.15 (63.21-83.13). Interpretation We showed that spatially connected graph models enable molecular profile predictions in colon cancer and are generalised to rectum cancer. After further validation, our method could be used to infer the prognostic value of multiscale molecular biomarkers and identify targeted therapies for patients with colon cancer. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.

Spatial characterization and stratification of colorectal adenomas by deep visual proteomics

Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis: A Digital Spatial Profiling Approach

Circulating Bacterial DNA As a Tool Towards Noninvasive Biomarkers for Colorectal Adenocarcinoma and Adenoma.

392P Integrating Fragmentomic Features for Non-Invasive Early Detection of Colorectal Advanced Adenoma and Adenocarcinoma

Digital spatial profiling identifies molecular changes involved in development of colitis-associated colorectal cancer

Exploring prognostic biomarkers in pathological images of colorectal cancer patients via deep learning

Metabolically Active Zones Involving Fatty Acid Elongation Delineated by DESI-MSI Correlate with Pathological and Prognostic Features of Colorectal Cancer

Spatial Proteomic Profiling of Colorectal Cancer Revealed Its Tumor Microenvironment Heterogeneity

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets

Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression

Abstract 4632: Spatial whole transcriptome analysis of differential expression for biomarker discovery in colorectal cancer

New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.

Tissue Biomolecular and Microstructure Profiles in Optical Colorectal Cancer Delineation

Spatially Aware Graph Neural Networks and Cross-Level Molecular Profile Prediction in Colon Cancer Histopathology: a Retrospective Multi-Cohort Study.

Converging deep learning and human-observed tumor-adipocyte interaction as a biomarker in colorectal cancer

Comprehensive serum proteomics profiles and potential protein biomarkers for the early detection of advanced adenoma and colorectal cancer

Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer

Novel digital tissue phenotypic signatures of distant metastasis in colorectal cancer

Stratification of Chemotherapy-Treated Stage III Colorectal Cancer Patients Using Multiplexed Imaging and Single Cell Analysis of T Cell Populations

From the genome to the proteome—biomarkers in colorectal cancer

In-Depth Proteomic Analysis of Paraffin-Embedded Tissue Samples from Colorectal Cancer Patients Revealed TXNDC17 and SLC8A1 as Key Proteins Associated with the Disease